Steven McAfee
Overview
Explore the profile of Steven McAfee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
899
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Newcomb R, Gao L, Vanderklish J, Tse A, Saylor M, Danielson C, et al.
Transplant Cell Ther
. 2024 Apr;
30(7):700-711.
PMID: 38685402
Allogeneic hematopoietic cell transplantation (HCT) survivors may benefit from routine screening for post-transplant complications. However, the impact of formal survivorship efforts to promote screening adherence is uncertain. The effect of...
2.
Bales J, Kim H, Portillo R, Patel C, McAfee S, Dey B, et al.
Bone Marrow Transplant
. 2023 Jan;
58(4):459-461.
PMID: 36624162
No abstract available.
3.
Frigault M, Dietrich J, Gallagher K, Roschewski M, Jordan J, Forst D, et al.
Blood
. 2022 Feb;
139(15):2306-2315.
PMID: 35167655
CD19-directed chimerical antigen receptor T-cell (CAR-T) products have gained US Food and Drug Administration approval for systemic large B-cell lymphoma. Because of concerns about potential immune cell-associated neurotoxicity syndrome (ICANS),...
4.
Amrein P, Ballen K, Stevenson K, Brunner A, Hobbs G, Hock H, et al.
Leuk Lymphoma
. 2022 Jan;
63(6):1428-1435.
PMID: 35075985
We sought to assess the safety of adding ixazomib, an oral proteasome inhibitor, to a multi-agent treatment regimen for older adults with acute lymphoblastic leukemia (ALL). Patients 51 to 75 ...
5.
Ott A, Venkataraman V, Badran Y, Goldman R, Spasic S, Vyas D, et al.
Clin Case Rep
. 2021 May;
9(5):e04115.
PMID: 34026155
Arsenic trioxide (ATO) is generally well tolerated for treatment of APL. We present a patient with severe watery diarrhea and pancreatitis thought to be due to ATO toxicity in the...
6.
Venkataraman V, Casey K, Onozato M, Dal Cin P, Nardi V, Amrein P, et al.
Leukemia
. 2020 Jul;
34(11):3050-3054.
PMID: 32678290
No abstract available.
7.
Maurer A, Li S, Hunter B, Luk S, ODonnell S, Dey B, et al.
Bone Marrow Transplant
. 2020 May;
55(12):2319-2321.
PMID: 32457426
No abstract available.
8.
Abboud A, Zamalloa J, Sellars M, Garza-Mayers A, Varshney A, Osborne M, et al.
Am J Med
. 2020 Feb;
133(9):e457-e459.
PMID: 32001226
No abstract available.
9.
Leick M, Hunter B, DeFilipp Z, Dey B, El-Jawahri A, Frigault M, et al.
Bone Marrow Transplant
. 2019 Oct;
55(4):758-762.
PMID: 31649343
We present a single-center retrospective series of allogeneic bone marrow transplantation (BMT) with the use of posttransplant cyclophosphamide (PTCy) in the setting of nonmalignant hematological conditions. Nine patients were treated...
10.
DeFilipp Z, Li S, Avigan D, Armand P, Ho V, Koreth J, et al.
Bone Marrow Transplant
. 2019 Oct;
55(4):804-810.
PMID: 31616065
In this multicenter Phase 2 single arm study, we substituted low dose total body irradiation (TBI) for antithymocyte globulin (ATG) in a reduced intensity conditioning regimen with the intent to...